Hyperlipidemia. Hyperlipidemia, unspecified
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Inclusion criteria: patients aged 20 to 60 years, patients with serum cholesterol level above 240 mg/dl, patients with serum triglyceride level above 240 mg/dl, patients recently diagnosed as hyperlipidemic, literate patients. Exclusion criteria: patients with serum cholesterol or triglyceride levels above 300 mg/dl, patients using other blood lipid lowering agents, patients with cardiac, renal, hepatic, hematological diseases, hypothyroidism, diabetes, tachycardia, vertigo and seizure, patients with a history of gallstones or gall bladder surgery, patients using estrogen, steroid, beta-blocker and thiazide, pregnant women, women planning pregnancy, breast-feeding women.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Blood serum cholesterol level of patients. Timepoint: 2 months. Method of measurement: Medical laboratory (kit).;Blood serum triglyceride level of patients. Timepoint: 2 months. Method of measurement: Medical laboratory (kit). | — |
Secondary
| Measure | Time frame |
|---|---|
| Blood serum LDL cholesterol level of patients. Timepoint: 2 months. Method of measurement: Medical laboratory (kit).;Blood serum HDL cholesterol level of patients. Timepoint: 2 months. Method of measurement: Medical laboratory (kit).;Blood serum creatinine level of patients. Timepoint: 2 months. Method of measurement: Medical laboratory (kit).;Blood serum SGOT level of patients. Timepoint: 2 months. Method of measurement: Medical laboratory (kit).;Blood serum SGPT level of patients. Timepoint: 2 months. Method of measurement: Medical laboratory (kit). | — |
Countries
Iran (Islamic Republic of)
Contacts
Institute of Medicinal Plants affiliated with the ACECR